RESULTS: Nanostring assay was successful in 91 of 111 primary clear cell RCC tumor specimens. Median follow-up for survivors was 108.0 months, during which 79 patients died from RCC. In primary tumors, 18 of 124 genes interrogated were univariately associated with RCC-specific survival (false discovery rate <0.10) and five genes were retained in the multivariable model. After adjusting for clinical and pathological indices previously shown to be predictive of survival in metastatic clear cell RCC, the five gene scoring algorithm remained highly significant (p<0.0001). When expression levels were determined in metastatic tissue, rather than the primary tumor tissue, the five gene scoring algorithm remained significantly associated with survival. CONCLUSIONS: We have identified a panel of genes that predict prognosis in patients with metastatic clear cell RCC and provides significant risk stratification after adjusting for existing models. These genes may provide insight into the biology of metastatic RCC and warrant further investigation.
INTRODUCTION AND OBJECTIVES: Older patients are more likely to be diagnosed with renal cell carcinoma and to have a lower overall survival based on age and associated co-morbidities. Decisions regarding the pursuit of surgical therapy are impacted by competing risks for perioperative mortality. We utilized the National Cancer Database (NCDB) to evaluate 90-day mortality and developed a nomogram predicting short-term mortality after renal cell carcinoma surgery.
METHODS: The NCDB for kidney cancer was queried to identify all patients with clinically localized, non-metastatic disease who were treated with partial or radical nephrectomy. Those patients with incomplete data were excluded. Logistic regression was performed on a random sample of 60% of the dataset to identify preoperative variables associated with 90-day mortality. Variables included age, sex, race, comorbidity score, tumor diameter, and presence of tumor thrombus. A nomogram was built from the logistic regression model and tested on the remaining 40% of the patients in the dataset for the ability to predict 90-day mortality. RESULTS: 183,407 patients were identified that met inclusion criteria (median age 61.1). Overall 90-day mortality for the cohort was 1.9%. Odds ratios for 90-day mortality using preoperative variables are shown in Table 1 . The nomogram ranged from 0-14 (Table 1) . Median (IQR) nomogram score was 2 (1-4). Twelve percent of patients had nomogram score of 6 or higher. Compared to patients with 0-1 points, those with 2-3 (OR 2.69, 2.26-3.20; p < 0.001), 4-5 (OR 5.98, 5.06-7.06; p < 0.001), and 6+ (OR 12.34, ; p < 0.001) were at incrementally significantly higher odds of 90-day mortality (Figure 1 ). Being greater than 80 years of age placed patients into the highest category of mortality.
CONCLUSIONS: Management of localized kidney cancer must consider competing causes of mortality, especially in elderly patients with multiple co-morbidities. We present a preoperative tool to calculate risk of surgical short-term mortality to aid in surgeon-patient counseling.
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